Explore 3 court opinions on Fda Drug Approval Process. AI-powered plain English summaries, key holdings, and legal analysis.
3 recent cases analyzed in this topic area.
Third Circuit Upholds Medicare Part D Drug Exclusion
Novartis Pharmaceuticals Corp v. Secretary United States Department of Health, decided by Third Circuit on September 11, 2025, resulted in a defendant win outcome. The Third Circuit affirmed the Distr...
D.C. Circuit Vacates FDA's Rejection of Vanda's Hetlioz sNDA
Vanda Pharmaceuticals, Inc. v. FDA, decided by D.C. Circuit on August 15, 2025, resulted in a mixed outcome. The D.C. Circuit reviewed the FDA's refusal to approve Vanda Pharmaceuticals' supplemental ...
Federal Circuit Clarifies Medicare Part D 'Substantially All' Drug Reimbursement Rule
Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...